David Rescott
Stock Analyst at Baird
(3.55)
# 840
Out of 4,876 analysts
60
Total ratings
55.1%
Success rate
4.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HAE Haemonetics | Initiates: Outperform | $87 | $74.77 | +16.36% | 1 | Jun 26, 2025 | |
MDT Medtronic | Maintains: Neutral | $94 → $92 | $86.18 | +6.75% | 5 | May 22, 2025 | |
LIVN LivaNova | Maintains: Outperform | $55 → $61 | $45.83 | +33.12% | 4 | May 8, 2025 | |
MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $92.80 | +18.53% | 3 | Apr 25, 2025 | |
PEN Penumbra | Maintains: Buy | $315 → $330 | $253.58 | +30.14% | 29 | Apr 24, 2025 | |
EW Edwards Lifesciences | Maintains: Neutral | $72 → $75 | $77.15 | -2.79% | 4 | Apr 24, 2025 | |
BSX Boston Scientific | Maintains: Outperform | $115 → $120 | $104.58 | +14.74% | 5 | Apr 24, 2025 | |
ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $534.19 | +7.64% | 3 | Apr 23, 2025 | |
SIBN SI-BONE | Maintains: Buy | $25 → $26 | $18.09 | +43.73% | 6 | Dec 22, 2023 |
Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $74.77
Upside: +16.36%
Medtronic
May 22, 2025
Maintains: Neutral
Price Target: $94 → $92
Current: $86.18
Upside: +6.75%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55 → $61
Current: $45.83
Upside: +33.12%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $92.80
Upside: +18.53%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $315 → $330
Current: $253.58
Upside: +30.14%
Edwards Lifesciences
Apr 24, 2025
Maintains: Neutral
Price Target: $72 → $75
Current: $77.15
Upside: -2.79%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $115 → $120
Current: $104.58
Upside: +14.74%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $534.19
Upside: +7.64%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $18.09
Upside: +43.73%